A carregar...
Pharmacologic Advances in the Treatment and Prevention of Respiratory Syncytial Virus
There are currently only two drugs approved for respiratory syncytial virus (RSV). Palivizumab is a monoclonal antibody for the prevention of RSV in high-risk children and ribavirin is approved for treatment of severe RSV disease, however its effectiveness in improving outcomes is questionable. Over...
Na minha lista:
| Main Authors: | , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2010
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2851489/ https://ncbi.nlm.nih.gov/pubmed/20235830 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1086/651603 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|